FDA approves remdesivir as first Covid-19 drug, and other related updates 🇧🇷 Brazil reports 33,862 new coronavirus cases, 497 deaths 🇬🇧 UK boosts business aid to ease virus impact 🇪🇺 Europe reports over 200,000 daily cases for the first time More here:
FILE PHOTO: An ampule of Gilead Sciences Covid-19 antiviral drug remdesivir is pictured during a news conference at the University Hospital Eppendorf in Hamburg, Germany, April 8, 2020. Europe's reported coronavirus cases have more than doubled in 10 days, crossing 200,000 daily infections for the first time, according to a Reuters tally, with many Southern European countries reporting their highest single-day cases this week.Europe has so far reported about 7.
According to a Reuters tally, Wednesday saw the highest total of infections reported in a single day across the world, at 422,835. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days – from 15 days to 10 on average – in a large study led by the US National Institutes of Health.
UK Treasury chief Rishi Sunak is increasing subsidies for bars, pubs and restaurants hammered by strict new measures to slow the spread of Covid-19, amid criticism that the government has failed to protect small businesses and workers from the economic hardship caused by the pandemic.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA extends Covid-19 vaccine meeting to allow public inputThe FDA has added extra time to a daylong meeting Thursday of its vaccine advisers. The meeting will now include at least an hour and a half for public input, according to an agenda posted online.
Weiterlesen »
U.S. FDA panel to discuss COVID-19 vaccine trials after emergency authorizationA panel of independent experts to the U.S. health regulator will decide on the nature of clinical trials that coronavirus vaccines should go through after receiving U.S. emergency use authorization.
Weiterlesen »
FDA Approves Remdesivir For Covid-19 TreatmentThe drug was previously granted emergency use authorization, not full approval.
Weiterlesen »
Gilead's remdesivir gets U.S. FDA approval for use in hospitalized COVID-19 patientsGilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October. Remdesivir, previously granted emergency use authorization by the FDA for COVID-19, was one of the drugs
Weiterlesen »
FDA approves remdesivir to treat Covid-19The US Food and Drug Administration has approved remdesivir for the treatment of coronavirus infection, according to the drug's maker, Gilead Sciences
Weiterlesen »